Izah Azahari Molnupiravir, the oral anti-viral pill, will only be given to high-risk COVID-19 adult patients, and the plan for its use has already been laid out by the Ministry of Health (MoH) prior to placing the order. This was shared by Minister at the Prime Minister’s Office and Minister of Finance and Economy II
